Company Description
Cephalon isn't asleep at the wheel. The company sells PROVIGIL, a treatment for the sleep disorder narcolepsy, in the US and select countries around...
Key Cephalon Financials
| Company Type | Public - NASDAQ (GS): CEPH Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $1,772.6 |
| 2007 Employees | 2,796 |
More Cephalon Financials (11 pages)
Latest Cephalon Jobs jobs by Indeed
Rankings
- S&P 400
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Cephalon's competition across multiple industries
Top Cephalon Competitors
Sponsored Links
The Business Directory
Cephalon Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | Frank Baldino Jr. | Network | E-mail |
| EVP Worldwide Technical Operations | Peter E. Grebow | Network | E-mail |
| SVP and CFO | J. Kevin Buchi | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Cephalon News
- Barr to challenge Irish drug maker's patent on FazaClo [Record (Hackensack, NJ)] (26 Aug 2008 04:00:00 EDT)
- Cephalon, Inc. (CEPH) Corporate Event Announcement Notice [Wall Street Horizon] (19 Aug 2008 20:41:00 EDT)
- BioWorld Today August 19, 2008 [BioWorld Today] (19 Aug 2008 00:01:00 EDT)
Sponsored Opportunity
